文献速递药物不良反应与药物警戒

促进监管机构与患者协作以提升药物安全与监管决策

Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making.
PubMed 文献 · Drug Saf · 2023-12-11

该文讨论药物警戒全生命周期中患者参与药物安全与监管决策的现状,指出亚太地区患者参与仍处于起步阶段,虽已有积极案例和趋势,但缺乏正式框架或平台、沟通与信息交换渠道不完善以及家长式卫生系统等系统性挑战阻碍了患者系统参与。解决这些挑战将推进监管机构、患者及患者倡导者的协作,从而提升药物安全与监管决策。

要点

  • 药物警戒需监管机构、企业、医疗机构、医务人员和患者等多方共同参与。
  • 亚太地区患者参与药物安全与监管决策仍处于起步阶段。
  • 缺乏正式框架、沟通渠道不完善和家长式卫生系统是主要障碍。

核心结论

  • 解决系统性挑战可推进监管机构、患者及患者倡导者协作,提升药物安全与监管决策。

研究设计与样本

  • 本文为药物警戒领域中患者参与药物安全与监管决策的综述性文章,未报告系统检索范围与样本量。

主要发现

  • 药物警戒是贯穿药品全生命周期持续评估、监测和沟通安全性的过程。
  • 患者是药品最终使用者且熟悉自身疾病,但亚太地区患者参与仍处于起步阶段。
  • 当前存在积极案例和鼓励性趋势,但多个关键挑战阻碍患者系统参与。

临床怎么用

  • 临床药学实践中应重视患者作为药物安全信息反馈者和监管决策参与者的角色。
  • 推动建立正式的患者参与框架与信息沟通渠道,促进监管机构与患者协作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacovigilance involves a continuous process of evaluating, monitoring and communicating the safety profile of a medicine throughout its life cycle. This process involves a range of stakeholders, including national regulatory authorities, industry, health organisations, healthcare providers and patients. Although patients are the end users of medicines and experts in their medical conditions, patient involvement is still nascent in the Asia-Pacific region. While there are positive examples and encouraging trends, several key challenges currently hinder systemic patient involvement in drug safety and regulatory decision making. Systemic issues such as a lack of formalised frameworks or platforms, underdeveloped communication and information exchange channels, and paternalistic health systems constrain greater patient involvement and collaborative regulator-patient activities. Addressing these challenges will greatly advance collaboration among regulators, patients, and patient advocates to enhance drug safety and regulatory decision making.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Khoo YK, Lim JCW, Tan-Koi WC, et al. Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making. Drug Saf. 2023. PMID: 38082120. doi:10.1007/s40264-023-01385-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。